Dr. Riyaz Bashir invents world’s first ever two catheters for removing clots

GMC Srinagar alumnus Dr. Riyaz Bashir has invented world’s first ever two catheters for removing clots, The Bashir™ Endovascular Catheter (BEC) and The Bashir N-X™ Endovascular Catheter (BEC N-X). He’s presently Professor of Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM) and Director of Vascular and Endovascular Medicine at Temple University Hospital, Philadelphia PA, USA.The U.S. Food and Drug Administration (FDA) has granted premarket notification clearance for two catheters invented by Riyaz Bashir, MD, FACC, RVT Professor of Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM) and Director of Vascular and Endovascular Medicine at Temple University Hospital, and Nicholas Green, Director of Research & Development at Thrombolex, Inc. Thrombolex is a company founded in partnership with Temple University to develop these catheter-based clot dissolving devices. This clearance now allows Thrombolex to commercialize the catheters. The Bashir™ Endovascular Catheter (BEC) is cleared for the controlled and selective infusion of fluids, including clot-dissolving medications, into the veins and arteries of the peripheral vasculature. The BEC is unique because it’s the only catheter of its kind that, once advanced into the clot, can be expanded by the physician into six expandable mini-catheters to deliver medications in precise locations throughout the cross section of the clot. The Bashir N-X™ Endovascular Catheter (BEC N-X) is cleared for the controlled and selective infusion of fluids chosen by the physician into both the peripheral and pulmonary vasculature, which is comprised of the blood vessels of the lungs. Unlike the BEC, the BEC N-X is not expandable.